BARCLAYS PLC - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q4 2022$97
-99.9%
44,013
-8.1%
0.00%
Q3 2022$97,000
-47.3%
47,8790.0%0.00%
Q2 2022$184,000
-32.6%
47,879
+7.9%
0.00%
Q1 2022$273,00044,3870.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q2 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,827,926$12,096,2468.11%
TCG Crossover Management, LLC 11,111,111$35,111,1115.17%
VR Adviser, LLC 14,444,444$45,644,4434.80%
Kynam Capital Management, LP 3,281,313$10,368,9491.70%
Ghost Tree Capital, LLC 1,325,000$4,187,0001.38%
Octagon Capital Advisors LP 2,777,778$8,777,7781.35%
RA Capital Management 18,472,503$58,373,1091.15%
RTW INVESTMENTS, LP 16,893,185$53,382,4651.13%
Diametric Capital, LP 760,014$2,401,6441.00%
Quantum Private Wealth, LLC 575,380$1,818,2010.87%
View complete list of TAYSHA GENE THERAPIES INC shareholders